Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
03/2005
03/16/2005EP1514930A1 Novel screening method
03/16/2005EP1514877A1 Complex of organic medicines and beta-cyclodextrin derivatives and its preparing process
03/16/2005EP1514867A2 Substituted phenyl derivatives, their preparation and use
03/16/2005EP1514559A1 Arylpiperazines having activity at the serotonin 1a receptor
03/16/2005EP1514552A1 Novel fused imidazole derivative
03/16/2005EP1513942A2 Galactosyl isomalt, method for production and use thereof
03/16/2005EP1513880A1 Epimerized derivatives of k5 polysaccharide with a very high degree of sulfation
03/16/2005EP1513864A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
03/16/2005EP1513862A2 Novel derivatives of androstane and androstene with ascorbic acid and use thereof in treating or preventing various conditions, diseases, and disorders
03/16/2005EP1513858A2 Process for the preparation of heterocyclyl substituted adenosine derivatives
03/16/2005EP1513848A2 Method of treating ischemia reperfusion injury using adenosine receptor antagonists
03/16/2005EP1513842A1 Substituted hexahydropyrrolo (1,2-a)pyrazines, octahydropyrido(1,2-a)pyrazines and decahydropyrazino(1,2-a)azepines
03/16/2005EP1513839A1 3-substituted quinuclidines and their use
03/16/2005EP1513837A1 Thiazole derivatives as phosphodiesterase iv inhibitors
03/16/2005EP1513836A1 Piperazinylacylpiperidine derivatives, their preparation and therapeutic use thereof
03/16/2005EP1513835A1 Piperazinylacylpiperidine derivatives, their preparation and therapeutic use thereof
03/16/2005EP1513834A1 Substituted thiophenes, method for the production thereof, their use as a medicament or diagnostic reagent, and a medicament containing the same
03/16/2005EP1513830A1 Bisindolyl-maleimid derivatives as kinase inhibitors
03/16/2005EP1513827A1 1,3,5-triazine derivatives as ligands for human adenosine-a3 receptors
03/16/2005EP1513820A2 Compounds, compositions, and methods
03/16/2005EP1513814A1 Novel piperidine compound
03/16/2005EP1513811A1 Non-peptidic brs-3 agonists
03/16/2005EP1513810A1 4-(aryl or heteroaryl) -2-butylamine derivatives and their use as glucocorticoid ligans
03/16/2005EP1513808A2 Fluorinated cyclic amides as dipeptidyl peptidase iv inhibitors
03/16/2005EP1513807A1 Pharmaceutical combination
03/16/2005EP1513806A1 New salts
03/16/2005EP1513797A1 Agents and methods for the treatment of disorders associated with oxidative stress
03/16/2005EP1513796A2 Phenyloxyalkanoic acid derivatives as hppar activators
03/16/2005EP1513795A2 Propionic acid derivatives and their use as hppars activators
03/16/2005EP1513588A2 Use of new etonogestrel esters
03/16/2005EP1513560A2 Method of magnetically manipulating a cell with magnetisable particles
03/16/2005EP1513555A1 Formulations of quinapril and related ace inhibitors
03/16/2005EP1513536A1 Use of compounds that stimulate cgmp
03/16/2005EP1513534A2 Compounds for increasing abca-1 expression useful for treating coronary artery disease and atherosclerosis
03/16/2005EP1513531A1 Basic non-peptide bradykinin antagonists and pharmaceutical compositions therefrom
03/16/2005EP1513526A1 Phenylalkanoic acid and phenyloxyalkanoic acid derivatives as hppar activators
03/16/2005EP1513522A2 Methods of treating conditions associated with an edg receptor
03/16/2005EP1513520A2 Substituted pyrrolines as kinase inhibitors
03/16/2005EP1513519A1 The use of substituted cyanopyrrolidines and combination preparations containing them for treating hyperlipidemia and associated diseases
03/16/2005EP1513516A1 SUBSTITUTED 3-AMINO-THIENO(2,3-b) PYRIDINE-2-CARBOXYLIC ACID AMIDE COMPOUNDS ANDPROCESSES FOR PREPARING AND THEIR USES
03/16/2005EP1513511A1 (2s)-2-amino-4- [2-(ethanimidoylamino)ethyl]thio butanoic acid, a nitric oxide synthase inhibitor, in stabilized pharmaceutical dosage forms
03/16/2005EP1513509A2 Nebulizer formulations of dehydroepiandrosterone and methods of treating asthma or chronic obstructive pulmonary disease using compostions thereof
03/16/2005EP1513496A1 Immediate release pharmaceutical formulation
03/16/2005EP1513495A1 Modified release pharmaceutical formulation
03/16/2005EP1513419A2 Method and composition for treating or preventing catabolism or stimulating anabolism in a mammal undergoing metabolic stress
03/16/2005EP1513404A1 Intramyocardial injection of autologous bone marrow
03/16/2005EP1513403A1 Cardiac glycosides to treat cystic fibrosis and other il-8 dependent disorders
03/16/2005EP1453510A4 Neurotransmitter balance chemotherapy
03/16/2005EP1425283B1 Novel 4-aminofuropyrimidines and the use thereof
03/16/2005EP1351962B1 Thienopyrimidine
03/16/2005EP1311476B1 Aza-amino acid derivatives (factor x a?-inhibitors 15)
03/16/2005EP1233959B1 Heterocyclo-alkylsulfonyl pyrazole derivatives as anti-inflammatory/analgesic agents
03/16/2005EP1226119B1 Tyrosine kinase inhibitors
03/16/2005EP1203585B1 Anti-ischemic agent
03/16/2005EP1171143B9 Peptide extract of lupine and pharmaceutical or cosmetic or nutritional composition comprising same
03/16/2005EP1140900B1 Pyrazole compounds and uses thereof
03/16/2005EP1140054B1 Bretylium compositions and kits, and their use in preventing and treating cardiovascular conditions
03/16/2005EP1117296B1 Combination of bisphosphonate and tetracycline
03/16/2005EP0869966B1 Prodrugs of thrombin inhibitors
03/16/2005EP0746321B1 Synthetic catalytic free radical scavengers useful as antioxidants for prevention and therapy of disease
03/16/2005CN1596313A Humanized collagen antibodies and related methods
03/16/2005CN1596266A Specific binding agents of human angiopoietin-2
03/16/2005CN1596263A Aryl fused azapolycyclic compounds
03/16/2005CN1596255A Chemokine receptor binding heterocyclic compounds with enhanced efficacy
03/16/2005CN1596253A Spiro-hydantoin compounds useful as anti-inflammatory agents
03/16/2005CN1596249A Benzoxazine and benzothiazine derivatives and parmaceutical compositions containing them
03/16/2005CN1596240A Chalcone derivatives and their use to treat diseases
03/16/2005CN1596128A Pharmaceutical compositions of 5, 7, 14-triazatetracyclo[10.3.1.0(2, 11).0(4, 9)]-hexadeca-2(11)3, 5, 7, 9-pentaene
03/16/2005CN1596127A Controlled release drug delivery composition comprising polycationic polymer and negatively charged pharmacologically active compound
03/16/2005CN1596125A Pharmaceutical composition comprising factor vii polypeptides and factor v polypeptides
03/16/2005CN1596122A Pharmaceutical composition comprising factor vii polypeptides and pai-1 polypeptides
03/16/2005CN1596121A Prevention and treatment of restenosis by local administration of drug
03/16/2005CN1596112A Benzothiazole derivatives
03/16/2005CN1596110A Use of an opuntia ficus-indica extract and compounds isolated therefrom for protecting nerve cells
03/16/2005CN1596106A Use of trifluoroacetyl alkyl-substituted phenyl derivatives, phenol derivatives, and benzoyl derivatives in the treatment and/or prophylaxis of obesity and accompanying diseases and/or secondary disea
03/16/2005CN1594578A Sea anemone neurotoxin gene Sr3 and application thereof
03/16/2005CN1594577A Sea anemone neurotoxin gene Sr4 and application thereof
03/16/2005CN1594576A Sea anemone neurotoxin gene Sr5 and application thereof
03/16/2005CN1594575A Sea anemone neurotoxin gene Sr6 and application thereof
03/16/2005CN1594574A Sea anemone neurotoxin gene Sr2 and application thereof
03/16/2005CN1594573A Sea anemone neurotoxin gene Sr1 and application thereof
03/16/2005CN1594572A Sea anemone neurotoxin gene Sr7 and application thereof
03/16/2005CN1594355A Cyclovirobuxinum D crystal, its mono-methanol crystal, and preparation and use thereof
03/16/2005CN1594307A Extraction separation for Nepal irid isoflavone from kudzu, process for preparing sulfonated compounds thereof , and their pharmaceutical uses
03/16/2005CN1594306A Genistein-3'-sodium sulfonate, dimethylation daidzein-3'-sodium sulfonate, their preparing process and pharmaceutical use
03/16/2005CN1594293A Process for synthesizing lacidipine of antihypertensive drugs
03/16/2005CN1594291A Process for preparing zofenopril
03/16/2005CN1594270A Novel L-2-(alpha-hydroxy pentyl)benzoate and its preparation method and use
03/16/2005CN1593656A Natural hirudin compound medicinal health products
03/16/2005CN1593655A Leading thrombolysis agent, preparation method and application thereof
03/16/2005CN1593643A Medicinal composition for preventing and treating cardiovascular heart disease and its preparation
03/16/2005CN1593632A Chinese Medicinal composition for treating coronary heart disease and preparation method thereof
03/16/2005CN1593629A Orally disintegrating tablet of 'Xinxuekang
03/16/2005CN1593626A Orally disintegrating tablet of 'Xintongning' and its preparation
03/16/2005CN1593624A Orally disintegrating tablet of gingko leaf and its preparation process
03/16/2005CN1593623A Orally disintegrating tablet of 'Tongxinluo' and its preparation
03/16/2005CN1593621A Orally disintegrating tablet of 'Shengmai' and its preparation
03/16/2005CN1593620A Detoxification Chinese medicine
03/16/2005CN1593617A Chinese patent medicine for promoting defecation to expelling toxin, nourishing skin and beautifying face
03/16/2005CN1593615A Orally disintegrating tablet of 'Mailuo Ning' and its preparation
1 ... 802 803 804 805 806 807 808 809 810 811 812 813 814 815 816 817 818 819 820 821 822 ... 1595